CDC Advisers to Vote on Johnson and Johnson Vaccine

The U.S. Center for Disease Control and Prevention’s vaccine advisers are meeting now and are revisiting the benefits and risks of the Johnson and Johnson vaccine. According to the agenda the committee is scheduled to vote on ‘updated recommendations for use’ of the single dose vaccine that is currently authorized for use in people 18 and older and can be used as a booster shot for adults fully vaccinated with Johnson and Johnson, Pfizer or Moderna vaccines. People who received the Johnson and Johnson vaccine are advised to get a booster of any of the authorized vaccines two months after their initial shot. About 16 million people have been fully vaccinated with the Johnson and Johnson vaccine in the United States, 73 million have gotten the Moderna vaccine and 113 million have received the Pfizer shot.